Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Pattamaporn BoonlerdAdisak TantiworawitLalita NorasetthadaChatree Chai-AdisaksophaTeerachat PunnachetNonthakorn HantrakunPokpong PiriyakhuntornThanawat RattanathammetheeSasinee HantrakoolEkarat Rattaritamrong

Published in: Annals of medicine (2023)

Efficacy between ESHAP and DICE regimens as salvage chemotherapy for relapsed or refractory DLBCL was not significantly different in terms of two-year PFS, two-year OS and ORR. DICE regimen had less renal AE than ESHAP.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
locally advanced
low dose
high dose
squamous cell carcinoma
radiation therapy
multiple myeloma
rectal cancer